Development and clinical application of bispecific antibody in the treatment of colorectal cancer.

Expert Review of Clinical Immunology
Maryam Balibegloo, Nima Rezaei

Abstract

Treatment of colorectal cancer as one of the most commonly diagnosed and a frequent cause of cancer-related deaths is of great challenges in health-related issues. Immunotherapy is the fourth pillar of cancer treatment which provides more novel therapeutic options with expanding investigational potentials. One of the modalities in immunotherapy is the use of bispecific antibodies. Despite demonstrating many promising roles, it still needs more advanced studies to identify the actual pros and cons. In this review, the application of bispecific antibody in the treatment of colorectal cancer has been explained, based on preclinical and clinical studies. The literature search was conducted mainly through PubMed in June and September 2019. Bispecific antibody is in its early stages in colorectal cancer treatment, requiring modern technologies in manufacturing, better biomarkers and more specific target antigens, more studies on individual genetic variations, and conducting later phase clinical trials and systematic reviews to achieve better survival benefits.

References

May 1, 1992·The Annals of Thoracic Surgery·M K McAfeeP C Pairolero
Sep 1, 1988·European Journal of Cancer & Clinical Oncology·A De GramontC Louvet
Mar 2, 1988·Journal of the National Cancer Institute·N WolmarkW Lawrence
Nov 23, 2000·Journal of Surgical Oncology·D RaysonL Stitt
Feb 27, 2001·Journal of Immunological Methods·D M SegalL M Weiner
Jun 14, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Ottavio RenaGiuliano Maggi
Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·David AzriaAndré Pèlegrin
Oct 24, 2003·Trends in Biotechnology·Lucy J HoltIan M Tomlinson
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Oct 11, 2005·Drug Discovery Today·Evelyn WolfPatrick A Baeuerle
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tristan D YanPaul H Sugarbaker
Apr 20, 2007·Journal of Surgical Oncology·Francesca ErroiDavide F D'Amico
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Philip KueblerNorman Wolmark
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Christel LarbouretDavid Azria
Mar 3, 2009·Methods in Molecular Biology·Tim D JonesMatthew P Baker
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thierry AndréAimery de Gramont
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George A PoultsidesPhillip B Paty
Dec 10, 2009·Molecular Cancer Therapeutics·Joan M CarboniMarco M Gottardis
Apr 14, 2010·Expert Opinion on Investigational Drugs·Shiran ShapiraSarah Kraus
Apr 24, 2010·Nature Reviews. Immunology·Louis M WeinerShangzi Wang
Jun 5, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joachim PfannschmidtHendrick Dienemann
Jul 2, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Carlo PulitanòO James Garden
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel G HallerHans-Joachim Schmoll
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Greg YothersNorman Wolmark
Mar 16, 2012·The Cochrane Database of Systematic Reviews·Sune Høirup PetersenSimone Mocellin
Mar 28, 2012·Cancer Cell International·Ana M Soto, Carlos Sonnenschein
Mar 29, 2012·MAbs·Roland E Kontermann
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Roberto CirocchiCameron Platell
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Hui RenTao Jiang
Oct 20, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Rafke SchoffelenOtto C Boerman
Jan 2, 2013·Frontiers in Bioscience (Landmark Edition)·Said Abdullah KhelwattyHelmout Modjtahedi
Feb 12, 2013·The Lancet Oncology·Martijn Hgm van der PasUNKNOWN COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group
Sep 21, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samuel T Workenhe, Karen L Mossman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

Advances in Experimental Medicine and Biology
H WangY Guo
Science
Ulrich Brinkmann, Roland E Kontermann
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
H Shinmoto, H Murakami
© 2022 Meta ULC. All rights reserved